Application of Real-Time Quantitative PCR to Molecular Analysis of Candida albicans Strains Exhibiting Reduced Susceptibility to Azoles by CHAU, Andrew S, MENDRICK, Cara A, SABATELLI, Frank J, LOEBENBERG, David, MCNICHOLAS, Paul M

Get full text

Mutations in Aspergillus fumigatus Resulting in Reduced Susceptibility to Posaconazole Appear To Be Restricted to a Single Amino Acid in the Cytochrome P450 14α-Demethylase by MANN, Paul A, PARMEGIANI, Raulo M, WEI, Shui-Qing, MENDRICK, Cara A, XIN LI, LOEBENBERG, David, DIDOMENICO, Beth, HARE, Roberta S, WALKER, Scott S, MCNICHOLAS, Paul M

Get full text

Changes in susceptibility to posaconazole in clinical isolates of Candida albicans by Li, Xin, Brown, Nathaniel, Chau, Andrew S., López-Ribot, José L., Ruesga, Maria T., Quindos, Guillermo, Mendrick, Cara A., Hare, Roberta S., Loebenberg, David, DiDomenico, Beth, McNicholas, Paul M.

Get full text

EmtA, a rRNA methyltransferase conferring high‐level evernimicin resistance by Mann, Paul A., Xiong, Liqun, Mankin, Alexander S., Chau, Andrew S., Mendrick, Cara A., Najarian, David J., Cramer, Christina A., Loebenberg, David, Coates, Elizabeth, Murgolo, Nicholas J., Aarestrup, Frank M., Goering, Richard V., Black, Todd A., Hare, Roberta S., McNicholas, Paul M.

Get full text

Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14alpha-demethylase by Mann, Paul A, Parmegiani, Raulo M, Wei, Shui-Qing, Mendrick, Cara A, Li, Xin, Loebenberg, David, DiDomenico, Beth, Hare, Roberta S, Walker, Scott S, McNicholas, Paul M

Get full text

Impact of Antifungal Prophylaxis on Colonization and Azole Susceptibility of Candida Species by MANN, Paul A, MCNICHOLAS, Paul M, CHAU, Andrew S, PATEL, Reena, MENDRICK, Cara, ULLMANN, Andrew J, CORNELY, Oliver A, PATINO, Hernando, BLACK, Todd A

Get full text

Discovery of a Novel Class of Orally Active Antifungal β-1,3-d-Glucan Synthase Inhibitors by WALKER, Scott S, YIMING XU, NORRIS, Christine, ANTONACCI, Barry, GURNANI, Maya, CACCIAPUOTI, Anthony, MCNICHOLAS, Paul M, WAINHAUS, Samuel, JASON HERR, R, KUANG, Rongze, ASLANIAN, Robert G, TING, Pauline C, TRIANTAFYLLOU, Ilias, BLACK, Todd A, WALDMAN, Michelle F, MENDRICK, Cara, BROWN, Nathaniel, MANN, Paul, CHAU, Andrew, PATEL, Reena, BAUMAN, Nicholas

Get full text

Interaction between Posaconazole and Caspofungin in Concomitant Treatment of Mice with Systemic Aspergillus Infection by Cacciapuoti, Anthony, Halpern, Judith, Mendrick, Cara, Norris, Christine, Patel, Reena, Loebenberg, David

Get full text

Clinical Evaluation of the Sensititre YeastOne Plate for Testing Susceptibility of Filamentous Fungi to Posaconazole by PATEL, Reena, MENDRICK, Cara, KNAPP, Cindy C, GRIST, Roger, MCNICHOLAS, Paul M

Get full text

Evernimicin (SCH27899) Inhibits a Novel Ribosome Target Site: Analysis of 23S Ribosomal DNA Mutants by ADRIAN, Peter V, MENDRICK, Cara, LOEBENBERG, David, MCNICHOLAS, Paul, SHAW, Karen J, KLUGMAN, Keith P, HARE, Roberta S, BLACK, Todd A

Get full text

In vitro and in vivo activities of SCH 56592 (Posaconazole), a new triazole antifungal agent, against Aspergillus and Candida by CACCIAPUOTI, A, LOEBENBERG, D, ARNOLD, B, ANTONACCI, B, PARMEGIANI, R, YAROSH-TOMAINE, T, MILLER, G. H, HARE, R. S, CORCORAN, E, MENZEL, F. JR, MOSS, E. L, NORRIS, C, MICHALSKI, M, RAYNOR, K, HALPERN, J, MENDRICK, C

Get full text

In Vitro and In Vivo Activities of SCH 56592 (Posaconazole), a New Triazole Antifungal Agent, againstAspergillus and Candida by Cacciapuoti, Anthony, Loebenberg, David, Corcoran, Erik, Menzel, Fred, Moss, Eugene L, Norris, Christine, Michalski, Monika, Raynor, Kimberly, Halpern, Judith, Mendrick, Cara, Arnold, Brian, Antonacci, Barry, Parmegiani, Raulo, Yarosh-Tomaine, Taisa, Miller, George H, Hare, Roberta S

Get full text